Abstract
BackgroundToll-like receptors (TLRs) are critical innate immune sensors that elicit antitumor immune responses in cancer immunotherapy. Although a few TLR agonists have been approved for the treatment of patients with...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have